Close

Citi Starts Olema Pharmaceuticals (OLMA) at Buy, 'Next-Gen Endocrine Therapy with Potential Across Multiple Lines of Breast Cancer'

January 30, 2024 5:02 AM EST Send to a Friend
(Updated - January 30, 2024 5:03 AM EST)

Citi analyst Yigal Nochomovitz initiates coverage on Olema Pharmaceuticals (NASDAQ: OLMA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login